Randomized trial to compare the efficacy and toxicity of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with methotrexate mitoxantrone (MM) in advanced carcinoma of the breast

One hundred and sixteen patients with locally advanced or metastatic breast cancer were randomized to receive CMF (cyclophosphamide 600 mg m(−2) day 1 and 8 i.v., 5-fluorouracil 600 mg m(−2) day 1 and 8 i.v.,, methotrexate 40 mg m(−2) day 1 and 8 i.v., monthly for 6 cycles) or MM (methotrexate 30 mg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Harper-Wynne, C, English, J, Meyer, L, Bower, M, Archer, C, Sinnett, H D, Lowdell, C, Coombes, R C
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1999
Teme:
Regular Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362871/
https://ncbi.nlm.nih.gov/pubmed/10496359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6990694
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items